ATRENEW INC (RERE) Fundamental Analysis & Valuation

NYSE:RERE • US00138L1089

Current stock price

5.045 USD
+0.04 (+0.7%)
Last:

This RERE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. RERE Profitability Analysis

1.1 Basic Checks

  • In the past year RERE was profitable.
  • RERE had negative earnings in each of the past 5 years.
  • In multiple years RERE reported negative operating cash flow during the last 5 years.
RERE Yearly Net Income VS EBIT VS OCF VS FCFRERE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

  • With a decent Return On Assets value of 5.34%, RERE is doing good in the industry, outperforming 73.98% of the companies in the same industry.
  • RERE has a Return On Equity of 7.28%. This is in the better half of the industry: RERE outperforms 62.60% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.72%, RERE is in the better half of the industry, outperforming 65.85% of the companies in the same industry.
Industry RankSector Rank
ROA 5.34%
ROE 7.28%
ROIC 6.72%
ROA(3y)-17.3%
ROA(5y)-20.7%
ROE(3y)-22.67%
ROE(5y)-27.41%
ROIC(3y)N/A
ROIC(5y)N/A
RERE Yearly ROA, ROE, ROICRERE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • The Profit Margin of RERE (1.44%) is comparable to the rest of the industry.
  • The Operating Margin of RERE (1.72%) is comparable to the rest of the industry.
  • RERE has a worse Gross Margin (12.19%) than 86.18% of its industry peers.
  • RERE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.72%
PM (TTM) 1.44%
GM 12.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.39%
GM growth 5Y35.71%
RERE Yearly Profit, Operating, Gross MarginsRERE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. RERE Health Analysis

2.1 Basic Checks

  • RERE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • There is no outstanding debt for RERE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RERE Yearly Shares OutstandingRERE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RERE Yearly Total Debt VS Total AssetsRERE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • RERE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.98
WACC6.84%
RERE Yearly LT Debt VS Equity VS FCFRERE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 3.30 indicates that RERE has no problem at all paying its short term obligations.
  • The Current ratio of RERE (3.30) is better than 90.24% of its industry peers.
  • RERE has a Quick Ratio of 2.77. This indicates that RERE is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.77, RERE belongs to the best of the industry, outperforming 93.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 2.77
RERE Yearly Current Assets VS Current LiabilitesRERE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. RERE Growth Analysis

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%26.75%

3.2 Future

  • Based on estimates for the next years, RERE will show a very strong growth in Earnings Per Share. The EPS will grow by 46.57% on average per year.
  • The Revenue is expected to grow by 23.96% on average over the next years. This is a very strong growth
EPS Next Y6.69%
EPS Next 2Y46.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.01%
Revenue Next 2Y23.96%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

RERE Yearly Revenue VS EstimatesRERE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B
RERE Yearly EPS VS EstimatesRERE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

3

4. RERE Valuation Analysis

4.1 Price/Earnings Ratio

  • RERE is valuated rather expensively with a Price/Earnings ratio of 18.69.
  • Based on the Price/Earnings ratio, RERE is valued a bit cheaper than 73.17% of the companies in the same industry.
  • RERE is valuated rather cheaply when we compare the Price/Earnings ratio to 25.54, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 17.24 indicates a rather expensive valuation of RERE.
  • RERE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. RERE is cheaper than 65.85% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 22.70. RERE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.69
Fwd PE 17.24
RERE Price Earnings VS Forward Price EarningsRERE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as RERE.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.1
RERE Per share dataRERE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RERE does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as RERE's earnings are expected to grow with 46.57% in the coming years.
PEG (NY)2.79
PEG (5Y)N/A
EPS Next 2Y46.57%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. RERE Dividend Analysis

5.1 Amount

  • RERE has a Yearly Dividend Yield of 1.95%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.79, RERE pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, RERE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.95%

5.2 History

  • RERE is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y46.57%
EPS Next 3YN/A
RERE Yearly Income VS Free CF VS DividendRERE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

More info and screens

Find the best dividend stocksShow peers with best dividend

RERE Fundamentals: All Metrics, Ratios and Statistics

ATRENEW INC

NYSE:RERE (3/24/2026, 3:48:09 PM)

5.045

+0.04 (+0.7%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-11
Earnings (Next)05-18
Inst Owners43.3%
Inst Owner Change9.46%
Ins OwnersN/A
Ins Owner Change0%
Market Cap1.12B
Revenue(TTM)N/A
Net Income(TTM)282.95M
Analysts85
Price Target7.57 (50.05%)
Short Float %1.19%
Short Ratio1.7
Dividend
Industry RankSector Rank
Dividend Yield 1.95%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.98%
Min EPS beat(2)-29.48%
Max EPS beat(2)-26.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.47%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)2.05%
Revenue beat(4)1
Avg Revenue beat(4)-0.31%
Min Revenue beat(4)-1.18%
Max Revenue beat(4)2.05%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)394.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 18.69
Fwd PE 17.24
P/S 0.39
P/FCF N/A
P/OCF N/A
P/B 1.98
P/tB 1.99
EV/EBITDA 11.1
EPS(TTM)0.27
EY5.35%
EPS(NY)0.29
Fwd EY5.8%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.86
BVpS2.54
TBVpS2.54
PEG (NY)2.79
PEG (5Y)N/A
Graham Number3.93
Profitability
Industry RankSector Rank
ROA 5.34%
ROE 7.28%
ROCE 8.51%
ROIC 6.72%
ROICexc 7.79%
ROICexgc 7.82%
OM 1.72%
PM (TTM) 1.44%
GM 12.19%
FCFM N/A
ROA(3y)-17.3%
ROA(5y)-20.7%
ROE(3y)-22.67%
ROE(5y)-27.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.39%
GM growth 5Y35.71%
F-ScoreN/A
Asset Turnover3.71
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 2.77
Altman-Z N/A
F-ScoreN/A
WACC6.84%
ROIC/WACC0.98
Cap/Depr(3y)21.04%
Cap/Depr(5y)18.67%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y6.69%
EPS Next 2Y46.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%26.75%
Revenue Next Year25.01%
Revenue Next 2Y23.96%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y930.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.16%
EBIT Next 3Y38.86%
EBIT Next 5YN/A
FCF growth 1Y267.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y163.56%
OCF growth 3YN/A
OCF growth 5YN/A

ATRENEW INC / RERE Fundamental Analysis FAQ

What is the fundamental rating for RERE stock?

ChartMill assigns a fundamental rating of 4 / 10 to RERE.


What is the valuation status for RERE stock?

ChartMill assigns a valuation rating of 4 / 10 to ATRENEW INC (RERE). This can be considered as Fairly Valued.


What is the profitability of RERE stock?

ATRENEW INC (RERE) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ATRENEW INC (RERE) stock?

The Price/Earnings (PE) ratio for ATRENEW INC (RERE) is 18.69 and the Price/Book (PB) ratio is 1.98.


What is the expected EPS growth for ATRENEW INC (RERE) stock?

The Earnings per Share (EPS) of ATRENEW INC (RERE) is expected to grow by 6.69% in the next year.